Cargando…
Progress in the production of haematopoietic stem and progenitor cells from human pluripotent stem cells
Cell therapies are currently used to treat many haematological diseases. These treatments range from the long-term reconstitution of the entire haematopoietic system using the most potent haematopoietic stem cells (HSCs) to the short-term rescue with mature functional end cells such as oxygen-carryi...
Autores principales: | Fidanza, Antonella, Forrester, Lesley M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350141/ https://www.ncbi.nlm.nih.gov/pubmed/34405125 http://dx.doi.org/10.1016/j.regen.2021.100050 |
Ejemplares similares
-
Concise review: programming human pluripotent stem cells into blood
por: Easterbrook, Jennifer, et al.
Publicado: (2016) -
Haematopoietic stem and progenitor cells from human pluripotent stem cells
por: Sugimura, Ryohichi, et al.
Publicado: (2017) -
Requirements for human haematopoietic stem/progenitor cells
por: Nan, Xue, et al.
Publicado: (2021) -
Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines
por: Philonenko, Elena S., et al.
Publicado: (2021) -
Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells
por: Yang, Cheng‐Tao, et al.
Publicado: (2017)